EZM0414

CAS No. 2411748-50-8

EZM0414( —— )

Catalog No. M28993 CAS No. 2411748-50-8

EZM0414 is a selective SEDT2 inhibitor that is mostly used to study diffuse large B lymphocytoma and recurrent or refractory multiple myeloma.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 619 Get Quote
10MG 880 Get Quote
25MG 1314 Get Quote
50MG 1764 Get Quote
100MG 2385 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    EZM0414
  • Note
    Research use only, not for human use.
  • Brief Description
    EZM0414 is a selective SEDT2 inhibitor that is mostly used to study diffuse large B lymphocytoma and recurrent or refractory multiple myeloma.
  • Description
    EZM0414 is a selective SEDT2 inhibitor that is mostly used to study diffuse large B lymphocytoma and recurrent or refractory multiple myeloma.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Histone Demethylase
  • Recptor
    HGPR91
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2411748-50-8
  • Formula Weight
    400.5
  • Molecular Formula
    C22H29FN4O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 120 mg/mL (299.63 mM)
  • SMILES
    CC(=O)N1CCN(CC1)[C@H]1CCC[C@H](C1)NC(=O)C1=CC2=C(F)C=CC(C)=C2N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Haffke M, et al. Structural basis of species-selective antagonist binding to the succinate receptor. Nature. 2019 Oct;574(7779):581-585.
molnova catalog
related products
  • KDM5A covalent inhib...

    KDM5A covalent inhibitor N73 is the the isopropyl ester derivative of N71.

  • DW14800

    DW14800 is an inhibitor of PRMT5 (IC50 = 17 nM), enhances the transcription of HNF4α, and reduces the level of H4R3me2s.

  • DDP-38003 dihydrochl...

    DDP-38003 is an novel, orally available inhibitor of histone lysine-specific demethylase 1A (KDM1A/LSD1) with IC50 of 84 nM.